Content
77%Weight 40%Scale 1-5Reviews the quality of instructions and guidance provided to agents. Good implementation is clear, handles edge cases, and produces reliable results.
A highly actionable, well-sequenced workflow skill whose tool-specific details (parameter quirks, output shapes, thresholds, fallbacks) are excellent. Its weaknesses are inlined reference material instead of progressive disclosure into separate files, and re-explanation of standard pharmacovigilance concepts Claude already knows.
Suggestions
Move the FAERS signal interpretation table, signal-credibility checklist, and evidence-grading tiers into a references/ file (e.g., FAERS-INTERPRETATION.md) linked one level deep from the relevant phase, keeping SKILL.md as an overview.
Trim or compress sections that re-teach known concepts — the channeling/notoriety/protopathic bias list and the standard PRR thresholds — down to the tool-specific deltas (which parameters differ, which values the tools return).
Consider offloading the Limitations and Edge Cases sections to a reference file and replacing them with a short pointer, reducing the always-loaded token footprint without losing fallback guidance.
| Dimension | Reasoning | Score |
|---|---|---|
Conciseness | Mostly efficient — tool parameter quirks, output shapes, and thresholds are novel and earn their tokens — but several sections re-teach concepts Claude already knows: the 'Signal ≠ Causation' bias list (channeling/notoriety/protopathic), the PRR threshold table reflecting standard Evans criteria, and the ICD-10 vs SNOMED data-harmonization paragraph, matching the 'mostly efficient but includes some unnecessary explanation' anchor. | 3 / 5 |
Actionability | Fully concrete, execution-ready guidance: exact tool names, parameter quirks flagged explicitly ('medicinalproduct', NOT 'drug_name'; 'setid', NOT 'set_id'; 'limit=1000'), output schemas, expected error shapes ('NOT_FOUND... is normal'), and specific signal criteria (PRR >= 2.0, lower CI > 1.0, N >= 3), covering the common cases per the instruction-skill scoring note. | 5 / 5 |
Workflow Clarity | Phases 0-6 are clearly sequenced, each with objective, tools, and numbered workflow, and include explicit checkpoints and error recovery: a 5-point signal-credibility checklist, T1-T4 evidence grading, edge-case fallbacks (new drug, OTC, combination products), and interpretation guidance for ambiguous results (MedDRA term-level mismatch, NOT_FOUND responses). | 5 / 5 |
Progressive Disclosure | The section structure is good, but there are no bundle files at all — all ~290 lines are inlined in SKILL.md, including content that naturally belongs in one-level-deep references (the FAERS interpretation guide, edge cases, and limitations), matching the 'some structure but content that should be separate is inline' anchor. | 3 / 5 |
Total | 16 / 20 Passed |